세계의 경피적 카테터 색전술 및 폐쇄 장치 시장 규모, 점유율, 성장 분석, 유형별, 용도별, 지역별 시장 규모, 점유율, 성장 분석 - 산업 예측(2024-2031년)

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.82 billion in 2023 to USD 8.41 billion by 2031, growing at a CAGR of 7.20% during the forecast period (2024-2031).

The global market for transcatheter embolization and occlusion devices has witnessed remarkable growth recently, driven by their effectiveness as minimally invasive solutions for obstructing or diminishing blood flow to abnormal vessels or tissues. These essential medical tools are pivotal in treating a range of conditions such as tumors, aneurysms, and vascular malformations. A notable factor propelling market demand is the escalating geriatric population, as older adults are more susceptible to cardiovascular diseases and various cancers, thereby increasing the necessity for minimally invasive treatment modalities. Additionally, the surge in healthcare expenditure, coupled with advancements in healthcare infrastructure across emerging economies, is further bolstering market expansion. These trends indicate a steady shift toward innovative medical technologies that offer safer and more efficient treatment options, positioning transcatheter embolization and occlusion devices as a critical component in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Embolization and Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Embolization and Occlusion Devices Market Segmental Analysis

Global Transcatheter Embolization and Occlusion Devices Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Coil, and Non-Coil. Based on Application, the market is segmented into Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market is significantly driven by the growing demand for minimally invasive treatment options. As healthcare continues to prioritize patient-centric care, both patients and medical professionals favor procedures that facilitate quicker recovery, shorter hospital stays, and a lowered likelihood of complications compared to traditional surgical approaches. This shift in preference not only reflects advancements in medical technology but also highlights the essential role of transcatheter embolization and occlusion devices in various therapeutic applications, thereby propelling market growth. Consequently, these devices are becoming integral to modern interventional radiology and vascular surgery practices.

Restraints in the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market faces significant restraint due to the potential complications and adverse events associated with these procedures. Despite their efficacy, risks such as device migration, vessel perforation, thrombosis, or allergic reactions to embolic agents may deter both healthcare providers and patients from opting for such interventions. These concerns not only decrease patient confidence but also compel clinicians to reconsider the choice of these devices over alternative treatment options, ultimately hindering market growth. Increased scrutiny and regulatory hurdles, fueled by these risks, may further challenge the adoption and advancement of transcatheter technologies.

Market Trends of the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market is witnessing significant growth, driven by the adoption of advanced technologies that enhance safety and efficacy. As the prevalence of chronic diseases rises, there is an increasing demand for minimally invasive procedures, further propelling market expansion. Additionally, favorable reimbursement policies are promoting greater utilization of these devices. Innovation is at the forefront, with emerging technologies continually improving treatment options and outcomes for various medical conditions. This confluence of factors positions the market for robust growth, as healthcare providers and patients increasingly recognize the benefits of transcatheter solutions.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Patent Analysis
• Regulatory Landscape
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Transcatheter Embolization and Occlusion Devices Market byType

• Market Overview
• Coil
  • Pushable Coils
  • Detachable Coils
• Non-Coil
  • Flow Diverting Devices
  • Embolization Particles
  • Liquid Embolics
  • Others

Transcatheter Embolization and Occlusion Devices Market byApplication

• Market Overview
• Peripheral Vascular Disease
  • Arterial Blockage
  • Venous Blood clot
  • Others
• Oncology
• Neurology
  • Brain Aneurysm
  • Cerebral Arteriovenous Malformations
  • Others
• Urology
  • Benign Prostatic Hyperplasia/Urinary Retention
  • Others
  • Varicocele
• Others

Transcatheter Embolization and Occlusion Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humares (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endospan Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SentreHEART, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments